LAS34273

· AstraZeneca

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LAS34273, covering 2012-11-01 to 2012-11-01. Get the full timeline:

Most recent: Clinical Trial Update: A Trial Assessing LAS34273 in Moderate to Severe Stable Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]